Publicacións nas que colabora con Amalia Lafuente (9)

2021

  1. Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

    Frontiers in Pharmacology, Vol. 12

2020

  1. Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period

    Journal of Psychopharmacology, Vol. 34, Núm. 5, pp. 514-523

  2. Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms

    Psychopharmacology, Vol. 237, Núm. 7, pp. 2151-2159

  3. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2019

  1. Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics (Translational Psychiatry, (2018), 8, 1, (276), 10.1038/s41398-018-0330-4)

    Translational Psychiatry

  2. One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 135-140

2018

  1. Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics

    Translational Psychiatry, Vol. 8, Núm. 1

2016

  1. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

2014

  1. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia

    Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387